Oct 2026· IEEE transactions on computational biology and bioinformatics· Vol PP· 0 citations
Medicine
TL;DR
Comprehensive evaluations across six benchmark datasets demonstrate that MMB-DTI achieves highly competitive predictive performance, significantly outperforming state-of-the-art baselines, and highlights that coupling linear-time state space modeling with topological complementarity yields a robust and discriminative paradigm for deciphering complex drug-target associations.
Abstract
Accurate drug-target interaction (DTI) prediction is fundamental to computational drug discovery. However, existing deep learning methods typically oversimplify biochemical entities as 1D sequences, neglecting crucial spatial topologies, and incur prohibitive quadratic computational costs when modeling long-range protein dependencies. To overcome these bottlenecks, we propose MMB-DTI, a novel multimodal framework that synergistically fuses evolutionary and chemical semantics, extracted via pre-trained language models (ESM-2 and ChemBERTa), with structural topologies derived from graph neural networks. At its core, the framework introduces a hybrid Mamba-BiLSTM architecture, leveraging a selective state space model for linear-time encoding of ultra-long-range protein sequences while precisely preserving local sequential motifs. Furthermore, a bidirectional cross-attention module simulates the biological "induced-fit" mechanism, dynamically capturing reciprocal and fine-grained binding affinities. Comprehensive evaluations across six benchmark datasets (Davis, KIBA, DrugBank, Enzymes, Ion Channels, and GPCRs) demonstrate that MMB-DTI achieves highly competitive predictive performance, significantly outperforming state-of-the-art baselines. Our results highlight that coupling linear-time state space modeling with topological complementarity yields a robust and discriminative paradigm for deciphering complex drug-target associations.
SF-DTI is a unified framework that integrates multi-encoder protein fusion, structure-semantic drug alignment, and progressive cross-modal refinement for DTI prediction and may support virtual screening, drug repositioning, and drug discovery.
Bo-Wen Wang, Xiao-Lan Xie, Hai-Tao Zou et al.· iScience· 0 citations
Efficient computational methods for predicting drug–target interactions (DTI) are crucial for drug discovery, shortening the development cycle, and reducing costs. Although deep learning has achieved remarkable progress in this field, existing methods often struggle to fully exploit complementary information betw...
Dong-Jie Chen, Yue-Meng Liu, Yu-Sheng Yi et al.· BMC Bioinformatics· 0 citations
Drug-target interaction (DTI) prediction is critical for drug discovery and repositioning. Existing methods often rely on coarse-grained representations and fail to capture the reciprocal nature of molecular recognition. We propose FGMDTI, a fine-grained multimodal framework that models bidirectional interactions betwe...
Meng-De Li, Chi Zhou, Wen-Bin Liu et al.· IEEE journal of biomedical a...· 0 citations
This paper proposes a sequence-only DTI prediction architecture that combines two pre-trained language models, ChemBERTa for drug SMILES strings and ESM-2 for protein amino acid sequences, with a hierarchical interaction module, and implements a sequential bidirectional cross-attention mechanism inspired by the induced...
Khadidja Henni, Hamza Abdelali, Abdelkrim Aries et al.· arXiv.org· 0 citations
Drug–target affinity (DTA) prediction plays an important role in computer-aided drug discovery, where reliable computational models can help prioritize compound–protein pairs before experimental validation. A key challenge in DTA prediction is to effectively mine multilevel molecular information from drug structures wh...
Huang-Chao Xu, Bao-Hua Zhang, Qian Liu et al.· ACS Omega· 0 citations
Drug-target affinity (DTA) prediction is crucial for advancing drug discovery and development, facilitating candidate prioritization and reducing experimental costs. However, accurate affinity prediction remains challenging, and most deep learning models often fail to generalize in scenarios involving novel drugs or ta...
Muhammad Habibulla Alamin, M. Rakib, Md. Sifat Ali et al.· IEEE transactions on computa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.